Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents.

[1]  E. Laurini,et al.  3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors. , 2011, European journal of medicinal chemistry.

[2]  T. O'Brien,et al.  Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells , 2011, Molecular Cancer Therapeutics.

[3]  Y. Sugimoto,et al.  Novel Acrylonitrile Derivatives, YHO-13177 and YHO-13351, Reverse BCRP/ABCG2-Mediated Drug Resistance In Vitro and In Vivo , 2011, Molecular Cancer Therapeutics.

[4]  Mark Tarleton,et al.  Library synthesis and cytotoxicity of a family of 2-phenylacrylonitriles and discovery of an estrogen dependent breast cancer lead compound , 2011 .

[5]  M. Radi,et al.  Practical one-pot two-step protocol for the microwave-assisted synthesis of highly functionalized rhodanine derivatives. , 2010, Journal of combinatorial chemistry.

[6]  A. Braithwaite,et al.  The Dynamin Inhibitors MiTMAB and OcTMAB Induce Cytokinesis Failure and Inhibit Cell Proliferation in Human Cancer Cells , 2010, Molecular Cancer Therapeutics.

[7]  M. Zavortink,et al.  Calcineurin activity is required for the completion of cytokinesis , 2010, Cellular and Molecular Life Sciences.

[8]  Kan Wang,et al.  Cyanoacetamide MCR (III): three-component Gewald reactions revisited. , 2010, Journal of combinatorial chemistry.

[9]  L. Cipak,et al.  Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leukemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. , 2009, Cancer letters.

[10]  S. Ackland,et al.  Norcantharidin Analogues: Synthesis, Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition , 2008, ChemMedChem.

[11]  M. Michaelis,et al.  Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents. , 2008, European journal of medicinal chemistry.

[12]  Mahabir P. Gupta,et al.  Synthesis and Evaluation of Novel E‐2‐(2‐Thienyl)‐ and Z‐2‐(3‐Thienyl)‐3‐Arylacrylonitriles as Antifungal and Anticancer Agents , 2007, Archiv der Pharmazie.

[13]  A. Tolmachev,et al.  Combinatorial Knoevenagel reactions. , 2007, Journal of combinatorial chemistry.

[14]  S. Ackland,et al.  Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. , 2007, Bioorganic & medicinal chemistry letters.

[15]  T. Inokuchi,et al.  E- or Z-selective Knoevenagel condensation of acetoacetic derivatives: effect of acylated substituent, that is, TEMPO and amines, as an auxiliary, and new accesses to trisubstituted E- and Z-2-alkenals and furans. , 2006, The Journal of organic chemistry.

[16]  R. Loddo,et al.  Synthesis and antiproliferative activity of 3-aryl-2-[1H(2H)-benzotriazol-1(2)-yl]acrylonitriles variously substituted: Part 4. , 2004, Farmaco.

[17]  P. Bednarski,et al.  Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles. , 2004, Journal of medicinal chemistry.

[18]  A. McCluskey,et al.  Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. , 2004, Bioorganic & medicinal chemistry letters.

[19]  S. Ackland,et al.  Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition of a New Generation of Cantharidin Analogues , 2002, Investigational New Drugs.

[20]  S. Ackland,et al.  Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition , 2004, Cancer Chemotherapy and Pharmacology.

[21]  Adam McCluskey,et al.  Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. , 2003, Bioorganic chemistry.

[22]  R. Loddo,et al.  Synthesis and antiproliferative activity of 3-aryl-2-(1H-benzotriazol-1-yl)acrylonitriles. Part III. , 2002, European journal of medicinal chemistry.

[23]  A. McCluskey,et al.  Green chemistry approaches to the Knoevenagel condensation: comparison of ethanol, water and solvent free (dry grind) approaches , 2002 .

[24]  S. Ackland,et al.  The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design? , 2001, Anti-cancer drug design.

[25]  E. Collins,et al.  Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. , 2000, Bioorganic & medicinal chemistry letters.

[26]  S. Ackland,et al.  Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells , 2000, Cancer Chemotherapy and Pharmacology.

[27]  R. Nakagawa,et al.  Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. , 1998, Journal of medicinal chemistry.

[28]  A. Levitzki,et al.  Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro. , 1996, Journal of medicinal chemistry.

[29]  G. Peters,et al.  Synergistic interaction between cisplatin and gemcitabine in vitro. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  G. Alberghina,et al.  1H‐NMR, Ultraviolet and infrared spectra of some (Z)‐α‐(phenyl)‐β‐(2‐furyl), ‐(2‐pyrrolyl) and ‐(N‐methyl‐2‐pyrrolyl)acrylonitriles , 1986 .

[31]  W. Herz,et al.  Pyrroles. XII. The Reaction of Pyrrolealdehydes with Arylacetonitriles1,2 , 1958 .